Key result
Primary percutaneous transluminal coronary angioplasty was more effective than thrombolytic therapy in decreasing plasma levels of 8-OHdG after reperfusion in acute myocardial infarction.
Why the study?
Does primary percutaneous transluminal coronary angioplasty reduce oxidative DNA damage compared to thrombolytic therapy in patients with acute myocardial infarction?
Observational
Does primary percutaneous transluminal coronary angioplasty reduce oxidative DNA damage compared to thrombolytic therapy in patients with acute myocardial infarction?
Primary PTCA appears more effective than thrombolytic therapy in reducing oxidative DNA damage (measured by 8-OHdG) after reperfusion in acute myocardial infarction.
May favor primary PTCA over thrombolysis to reduce oxidative damage in AMI; leaves open impact on clinical outcomes.
PURPOSE: Myocardial damage mediated by oxidative stress during acute myocardial infarction (MI) has been suggested as an obstructive factor on recovery after an MI. 8-Hydroxydeoxyguanosine (8-OHdG) is a marker for oxidative DNA damage; superoxide dismutase (SOD) and glutathione peroxidase (G-Px) are major antioxidant enzymes. We determined changes in the plasma level of 8-OHdG and activities of SOD and G-Px in patients with MI and examined the relations between those changes and other cardiac markers. METHODS: Blood samples were taken at the beginning of the therapy, on the third day of hospitalization, and on the day patients were discharged home. Plasma level of 8-OHdG and SOD and G-Px activities were measured by enzyme-linked immunosorbent assay and spectrophotometric kits, respectively. RESULTS: 8-Hydroxydeoxyguanosine level at the beginning of the therapy was found to be decreased on the third day of therapy and on the day patients were discharged home. With respect to the treatment way, 8-OHdG level was found to be slightly decreased on the third day of therapy and then remained stable in the group treated with thrombolytic agents. However, 8-OHdG level was found to be sharply decreased on the third day of therapy in the group that underwent primary percutaneous transluminal coronary angioplasty. No significant relations were determined between those measured parameters and serum levels of cardiac markers. CONCLUSION: Although not correlated with other cardiac markers, plasma level of 8-OHdG shows a decrease after reperfusion therapy in patients with MI, and primary percutaneous transluminal coronary angioplasty seems much more effective than thrombolytic therapy for providing a low level of 8-OHdG.
No takes yet. Share an insight, caveat, or question.
Himmetoğlu et al. (2009) conducted an observational in Acute Myocardial Infarction. Primary percutaneous transluminal coronary angioplasty vs. Thrombolytic therapy was evaluated on Plasma level of 8-OHdG. Primary percutaneous transluminal coronary angioplasty was more effective than thrombolytic therapy in decreasing plasma levels of 8-OHdG after reperfusion in acute myocardial infarction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: